Literature DB >> 6428243

Response to hyperventilation in a group of patients with panic disorder.

J M Gorman, J Askanazi, M R Liebowitz, A J Fyer, J Stein, J M Kinney, D F Klein.   

Abstract

Twelve patients with DSM-III diagnoses of panic disorder and four normal volunteers were studied during hyperventilation of room air and increased ventilation stimulated by 5% CO2. Patients also underwent sodium lactate infusion. Eight of the patients had a panic attack during sodium lactate infusion, seven during CO2 inhalation, and three during room-air hyperventilation. Since CO2 increases the firing of the locus ceruleus, and since sodium lactate infusion is known to increase cerebral CO2, these findings are consistent with other evidence implicating the locus ceruleus in panic anxiety.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6428243     DOI: 10.1176/ajp.141.7.857

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  32 in total

1.  Controlled cross-over study in normal subjects of naloxone-preceding-lactate infusions; respiratory and subjective responses: relationship to endogenous opioid system, suffocation false alarm theory and childhood parental loss.

Authors:  M Preter; S H Lee; E Petkova; M Vannucci; S Kim; D F Klein
Journal:  Psychol Med       Date:  2010-05-06       Impact factor: 7.723

2.  Single-unit analysis of sympathetic nervous discharges in patients with panic disorder.

Authors:  Elisabeth Lambert; Elodie Hotchkin; Marlies Alvarenga; Ciaran Pier; Jeffrey Richards; David Barton; Tye Dawood; Murray Esler; Gavin Lambert
Journal:  J Physiol       Date:  2005-11-24       Impact factor: 5.182

Review 3.  Orexin, stress, and anxiety/panic states.

Authors:  Philip L Johnson; Andrei Molosh; Stephanie D Fitz; William A Truitt; Anantha Shekhar
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

4.  Evaluating the risks of clinical research: direct comparative analysis.

Authors:  Annette Rid; Emily Abdoler; Roxann Roberson-Nay; Daniel S Pine; David Wendler
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-09       Impact factor: 2.576

Review 5.  The Deakin/Graeff hypothesis: focus on serotonergic inhibition of panic.

Authors:  Evan D Paul; Philip L Johnson; Anantha Shekhar; Christopher A Lowry
Journal:  Neurosci Biobehav Rev       Date:  2014-03-21       Impact factor: 8.989

Review 6.  Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.

Authors:  Borwin Bandelow; David Baldwin; Marianna Abelli; Blanca Bolea-Alamanac; Michel Bourin; Samuel R Chamberlain; Eduardo Cinosi; Simon Davies; Katharina Domschke; Naomi Fineberg; Edna Grünblatt; Marek Jarema; Yong-Ku Kim; Eduard Maron; Vasileios Masdrakis; Olya Mikova; David Nutt; Stefano Pallanti; Stefano Pini; Andreas Ströhle; Florence Thibaut; Matilde M Vaghi; Eunsoo Won; Dirk Wedekind; Adam Wichniak; Jade Woolley; Peter Zwanzger; Peter Riederer
Journal:  World J Biol Psychiatry       Date:  2016-07-15       Impact factor: 4.132

7.  Rebreathing to cope with hyperventilation: experimental tests of the paper bag method.

Authors:  M A van den Hout; C Boek; G M van der Molen; A Jansen; E Griez
Journal:  J Behav Med       Date:  1988-06

Review 8.  Is a Mask That Covers the Mouth and Nose Free from Undesirable Side Effects in Everyday Use and Free of Potential Hazards?

Authors:  Kai Kisielinski; Paul Giboni; Andreas Prescher; Bernd Klosterhalfen; David Graessel; Stefan Funken; Oliver Kempski; Oliver Hirsch
Journal:  Int J Environ Res Public Health       Date:  2021-04-20       Impact factor: 3.390

9.  Body fluids after CO2 inhalation: insight into panic mechanisms?

Authors:  E Griez; M A van den Hout; F Verstappen
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987

10.  Assessment of erectogenic properties of apomorphine and yohimbine in man.

Authors:  P Danjou; L Alexandre; D Warot; L Lacomblez; A J Puech
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.